Shareholder Votes

Vera Therapeutics, Inc. shareholders approved Ratification of the Appointment of Independent Registered Public Accounting Firm at the 2026-05-21 meeting.

“Proposal 2 – Ratification of the Appointment of Independent Registered Public Accounting Firm. The Company’s stockholders ratified the selection by the Audit Committee of the Company’s Board of Directors of KPMG LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. The final voting results are as follows: For Against Abstain 61,834,842 44,710 87,298”

Vera Therapeutics, Inc. shareholders approved Election of Directors at the 2026-05-21 meeting.

“Proposal 1– Election of Directors. The Company’s stockholders elected the three persons listed below as Class II Directors, each to serve until the Company’s 2029 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified, or, if sooner, such director’s death, resignation or removal. The final voting results are as follows: Votes For Votes Withheld Broker Non-Votes Michael M. Morrisey, Ph.D. 45,288,710 13,814,671 2,863,469 Patrick G. Enright 54,697,296 4,406,085 2,863,469 James R. Meyers 58,946,269 157,112 2,863,469”

TaskUs, Inc. shareholders approved Ratification of Appointment of KPMG LLP as Independent Registered Public Accounting Firm at the 2026-05-21 meeting.

“For Against Abstain Broker Non-Votes 580,193,071 143,134 18,233 0”

TaskUs, Inc. shareholders approved Election of Class II Directors at the 2026-05-21 meeting.

“For Withheld Broker Non-Votes Jaspar Weir 574,749,347 942,204 4,662,887 Michelle Gonzalez 575,621,993 69,558 4,662,887 Amit Dalmia 574,737,643 953,908 4,662,887”

Viking Therapeutics, Inc. shareholders approved Approve, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the Proxy Statement at the 2026-05-19 meeting.

“Proposal No. 3. To approve, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the Proxy Statement: Votes For Votes Against Abstentions Broker Non-Votes 30,045,938 12,763,135 401,396 36,879,063”

Viking Therapeutics, Inc. shareholders approved Ratify the selection of CBIZ CPAs P.C. as the Company’s independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-05-19 meeting.

“Proposal No. 2. To ratify the selection of CBIZ CPAs P.C. as the Company’s independent registered public accounting firm for its fiscal year ending December 31, 2026: Votes For Votes Against Abstentions 78,368,957 1,241,969 478,606”

Viking Therapeutics, Inc. shareholders approved Elect J. Matthew Singleton and S. Kathryn Rouan, Ph.D. as Class II directors at the 2026-05-19 meeting.

“Proposal No. 1. To elect the following nominees as Class II directors to serve until the Company’s 2029 annual meeting of stockholders or until such director’s respective successor is duly elected and qualified: Director Nominee Votes For Votes Withheld Broker Non-Votes J. Matthew Singleton 28,648,459 14,562,012 36,879,061 S. Kathryn Rouan, Ph.D. 21,960,203 21,250,268 36,879,061”

TUTOR PERINI CORP shareholders approved Approval of the Compensation of the Company’s Named Executive Officers on an Advisory (Non-binding) Basis.

“The Company’s shareholders cast their votes with respect to the approval of the compensation of the Company's named executive officers on an advisory (non-binding) basis. The final voting results on this proposal were as follows: Votes For Votes Against Abstentions Broker Non-Votes 38,631,812 952,357 283,064 5,960,026”

TUTOR PERINI CORP shareholders approved Ratification of Appointment of Independent Auditor at the 2026-12-31 meeting.

“The Company's shareholders ratified the appointment of Deloitte & Touche LLP, an independent registered public accounting firm, as independent auditors of the Company for the year ending December 31, 2026. The final voting results on this proposal were as follows: Votes For Votes Against Abstentions Broker Non-Votes 44,877,918 937,200 12,141 0”

TUTOR PERINI CORP shareholders approved Election of Directors.

“The Company's shareholders elected each of the following 10 nominees for director to serve until the Company's 2027 Annual Meeting of Shareholders and until their respective successors are duly elected and qualified. The final voting results for the election of directors were as follows: Elected Directors Votes For Votes Against Abstentions Broker Non-Votes Ronald N. Tutor 38,926,119 917,257 23,857 5,960,026 Gary G. Smalley 39,410,176 436,392 20,665 5,960,026 Peter Arkley 38,956,354 891,377 19,502 5,960,026 Jigisha Desai 36,091,008 3,755,431 20,794 5,960,026 Sidney J. Feltenstein 39,169,454 675,126 22,653 5,960,026 Robert C. Lieber 39,067,451 775,638 24,144 5,960,026 Dennis D. Oklak 39,483,643 359,446 24,144 5,960,026 Raymond R. Oneglia 38,220,426 1,622,382 24,425 5,960,026 Dale Anne Reiss 38,815,159 1,028,579 23,495 5,960,026 Shahrokh (“Rock”) Shah 39,522,340 318,864 26,029 5,960,026”

OMNICELL, INC. shareholders approved Ratification of the Selection of Independent Registered Public Accounting Firm at the 2026-05-19 meeting.

“Proposal No. 5: Ratification of the Selection of Independent Registered Public Accounting Firm”

OMNICELL, INC. shareholders approved Approval of an Amendment to the Company’s Amended and Restated Certificate of Incorporation at the 2026-05-19 meeting.

“Proposal No. 4: Approval of an Amendment to the Company’s Amended and Restated Certificate of Incorporation”

OMNICELL, INC. shareholders approved Approval of an Amendment to the Omnicell, Inc. 2009 Equity Incentive Plan, as Amended at the 2026-05-19 meeting.

“Proposal No. 3: Approval of an Amendment to the Omnicell, Inc. 2009 Equity Incentive Plan, as Amended”

OMNICELL, INC. shareholders approved Advisory Vote to Approve Named Executive Officer Compensation at the 2026-05-19 meeting.

“Proposal No. 2: Advisory Vote to Approve Named Executive Officer Compensation”

OMNICELL, INC. shareholders approved Election of Three Class I Directors at the 2026-05-19 meeting.

“Proposal No. 1: Election of Three Class I Directors to Hold Office Until the 2029 Annual Meeting of Stockholders”

Callaway Golf Co shareholders approved Advisory Vote on Executive Compensation at the 2026-05-21 meeting.

“Proposal 3: Advisory Vote on Executive Compensation The Company’s shareholders approved, on an advisory basis, the compensation of the Company’s named executive officers. The following sets forth the results of the voting with respect to this proposal: Shares Voted For Against Abstentions Broker Non-Votes 136,918,067 8,942,872 585,222 13,927,308”

Callaway Golf Co shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-05-21 meeting.

“Proposal 2: Ratification of Appointment of Independent Registered Public Accounting Firm The Company’s shareholders ratified, on an advisory basis, the Audit Committee’s appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The following sets forth the results of the voting with respect to this proposal: Shares Voted For Against Abstentions 156,259,310 3,553,082 561,077”

Callaway Golf Co shareholders approved Annual Election of Directors at the 2026-05-21 meeting.

“Proposal 1: Annual Election of Directors The voting results for the annual election of directors are as follows: Shares Voted Name of Candidate For Against Abstain Broker Non-Votes Oliver G. (Chip) Brewer III 144,881,105 1,012,437 552,619 13,927,308 John F. Lundgren 141,187,733 4,702,183 556,245 13,927,308 Thomas G. Dundon 143,624,916 2,266,864 554,381 13,927,308 Russell L. Fleischer 143,052,952 2,837,157 556,052 13,927,308 Bavan M. Holloway 144,382,805 1,507,326 556,030 13,927,308 Mark D. Mandel 145,294,838 594,819 556,504 13,927,308 Adebayo O. Ogunlesi 136,193,872 9,691,484 560,805 13,927,308 Linda B. Segre 142,072,235 3,799,761 574,165 13,927,308 Anthony S. Thornley 142,124,785 3,763,640 557,736 13,927,308”

STONERIDGE INC shareholders approved Approve Amendment No. 1 to the Stoneridge, Inc. 2025 Long-Term Incentive Plan.

“4. The proposal to approve Amendment No. 1 to the Stoneridge, Inc. 2025 Long-Term Incentive Plan was approved by the following votes: For Against Abstain Broker Non-Votes 17,773,424 3,557,150 127,742 2,620,208”

STONERIDGE INC shareholders approved Advisory resolution to approve 2025 compensation of Named Executive Officers.

“3. A non-binding advisory resolution to approve the 2025 compensation paid to the Company’s Named Executive Officers was approved by the following votes: For Against Abstain Broker Non-Votes 15,986,309 5,458,156 13,851 2,620,208”

STONERIDGE INC shareholders approved Ratify appointment of Ernst & Young LLP as independent registered public accounting firm for 2026 at the 2026-12-31 meeting.

“2. The proposal to ratify the appointment of Ernst & Young LLP, as the Company’s independent registered public accounting firm for the year ending December 31, 2026 was approved by the following votes: For Against Abstain Broker Non-Votes 23,883,582 194,854 88 —”

STONERIDGE INC shareholders approved Election of nine directors for one-year terms.

“At the 2026 Annual Meeting the following matters were voted on by the Company’s shareholders. The matters voted upon and the results, as certified by the Inspector of Elections, were as follows: 1. The nine Company nominees for election to the Board of Directors were elected, each for a one-year term, by the following votes: Nominee For Withheld Broker Non-Votes Aron R. English 21,416,977 41,339 2,620,208 Ira C. Kaplan 18,487,949 2,970,367 2,620,208 Kim Korth 17,981,620 3,476,696 2,620,208 William M. Lasky 19,394,736 2,063,580 2,620,208 Natalia Noblet 21,282,594 175,722 2,620,208 Carsten J. Reinhardt 20,842,937 615,379 2,620,208 Sheila Rutt 20,338,981 1,119,335 2,620,208 Frank S. Sklarsky 20,744,637 713,679 2,620,208 James Zizelman 21,267,549 190,767 2,620,208”

Ardent Health, Inc. shareholders approved Ratification of Ernst & Young LLP as independent registered public accounting firm at the 2026-05-20 meeting.

“The stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026, as follows: For Against Abstentions Broker Non-Votes 97,852,830 918,233 7,763 0”

Ardent Health, Inc. shareholders approved Advisory vote on executive compensation at the 2026-05-20 meeting.

“The stockholders approved on a non-binding advisory basis the compensation paid by the Company to its named executive officers, as disclosed in the Company’s Definitive Proxy Statement on Schedule 14A, filed with the Securities and Exchange Commission on April 8, 2026, as follows: For Against Abstentions Broker Non-Votes 91,093,535 300,746 184,475 7,200,070”

Ardent Health, Inc. shareholders approved Election of 11 director nominees at the 2026-05-20 meeting.

“The following 11 director nominees were elected to the Company's Board of Directors, as follows: For Withhold Broker Non-Votes Mark Sotir 90,717,572 861,184 7,200,070 Martin J. Bonick 91,240,732 338,024 7,200,070 Peter Bulgarelli 91,267,887 310,869 7,200,070 Peter Bynoe 87,141,918 4,436,838 7,200,070 Suzanne Campion 91,271,694 307,062 7,200,070 Robert A. DeMichiei 91,243,922 334,834 7,200,070 William Goodyear 91,243,902 334,854 7,200,070 Ellen Havdala 86,273,698 5,305,058 7,200,070 Edmondo Robinson 91,328,193 250,563 7,200,070 Rahul Sen 79,335,440 12,243,316 7,200,070 Rob Webb 91,362,871 215,885 7,200,070”

Northwest Bancshares, Inc. shareholders approved Approval of the Northwest Bancshares, Inc. Discounted Stock Purchase Plan at the 2026-05-20 meeting.

“The shareholders approved the proposal regarding the Discounted Stock Purchase Plan as disclosed in the Proxy Statement as follows: For 93,563,437 Against 3,061,203 Abstain 404,445 Broker Non-Votes 19,326,865”

Northwest Bancshares, Inc. shareholders approved Approval of the Northwest Bancshares, Inc. 2026 Equity Incentive Plan at the 2026-05-20 meeting.

“The shareholders approved the proposal regarding the 2026 Equity Incentive Plan as disclosed in the Proxy Statement as follows: For 92,456,593 Against 4,152,782 Abstain 419,710 Broker Non-Votes 19,326,865”

Northwest Bancshares, Inc. shareholders approved Advisory resolution to approve executive compensation at the 2026-05-20 meeting.

“The shareholders approved the proposal regarding the compensation of the named executive officers as disclosed in the Proxy Statement as follows: For 89,274,329 Against 7,171,131 Abstain 583,625 Broker Non-Votes 19,326,865”

Northwest Bancshares, Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-05-20 meeting.

“The shareholders approved the ratification of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. For 114,141,735 Against 1,967,195 Abstain 247,020 Broker Non-Votes —”

Northwest Bancshares, Inc. shareholders approved Election of Directors at the 2026-05-20 meeting.

“The shareholders elected the following Directors: For Withheld Broker Non-Votes Charles E. Kranich, II 95,639,086 1,389,999 19,326,865 Amber L. Williams 91,039,368 5,989,717 19,326,865 Louis J. Torchio 94,154,722 2,874,363 19,326,865”

Howmet Aerospace Inc. shareholders approved Advisory vote on executive compensation at the 2026-05-19 meeting.

“Item 3. The advisory vote on executive compensation was approved, based upon the following votes: For Against Abstain Broker Non-Votes 243,199,451 99,027,657 376,895 22,308,137”

Howmet Aerospace Inc. shareholders approved Ratify appointment of PricewaterhouseCoopers LLP as independent auditor for 2026 at the 2026-05-19 meeting.

“Item 2. The proposal to ratify the appointment of PricewaterhouseCoopers LLP to serve as the Company’s independent registered public accounting firm for 2026 was approved, based upon the following votes: For Against Abstain Broker Non-Votes 342,356,156 22,372,401 183,583 0”

Howmet Aerospace Inc. shareholders approved Election of nine director nominees at the 2026-05-19 meeting.

“Item 1. Each of the nine director nominees named in the 2026 Proxy Statement for election to the Company’s Board of Directors was elected for a one-year term expiring on the date of the Company’s 2027 annual meeting of shareholders, based upon the following votes: Nominees For Against Abstain Broker Non-Votes James F. Albaugh 325,838,316 16,610,826 154,861 22,308,137 Amy E. Alving 337,014,323 5,246,569 343,111 22,308,137 Sharon R. Barner 332,641,238 9,814,692 148,073 22,308,137 Joseph S. Cantie 341,328,735 1,116,810 158,458 22,308,137 Robert F. Leduc 341,231,086 1,213,560 159,357 22,308,137 Jody G. Miller 338,949,940 3,506,761 147,302 22,308,137 John C. Plant 327,527,896 14,909,493 166,614 22,308,137 Ulrich R. Schmidt 337,797,633 4,630,218 176,152 22,308,137 Gunner S. Smith 341,258,544 1,180,136 165,323 22,308,137”

PG&E Corp shareholders approved Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for 2026 at the 2026-05-21 meeting.

“Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for 2026 (included as Proposal 3 in the proxy statement): For: 1,799,578,512 Against: 133,964,864 Abstain: 12,446,594”

PG&E Corp shareholders approved Non-binding advisory vote to approve the company's executive compensation at the 2026-05-21 meeting.

“Non-binding advisory vote to approve the company’s executive compensation (included as Proposal 2 in the proxy statement): For: 1,670,209,325 Against: 168,851,135 Abstain: 12,443,857 Broker Non-Vote (1) 94,215,653”

PG&E Corp shareholders approved Election of directors of PG&E Corporation at the 2026-05-21 meeting.

“Election of the following individuals to serve as directors until the next annual meeting of shareholders or until their successors are elected and qualified (included as Proposal 1 in the proxy statement): For Against Abstain Broker Non-Vote (1) Rajat Bahri 1,833,250,034 6,042,619 12,211,664 94,215,653”

Jackson Financial Inc. shareholders approved Non-binding advisory vote to approve executive compensation at the 2026-05-21 meeting.

“shareholders, by non-binding advisory vote, approved the executive compensation of the Company’s named executive officers. Voting results on this proposal were as follows: For Against Abstain Broker Non-Vote 54,284,534 1,040,877 284,215 6,963,701”

Jackson Financial Inc. shareholders approved Ratification of KPMG LLP as independent auditor at the 2026-05-21 meeting.

“shareholders ratified the appointment of KPMG LLP as Jackson Financial Inc.’s independent auditor for the fiscal year ending December 31, 2026. Voting results on this proposal were as follows: For Against Abstain 60,759,089 1,784,842 29,396”

Jackson Financial Inc. shareholders approved Election of Directors at the 2026-05-21 meeting.

“Director Nominee For Against Abstain Lily Fu Claffee 55,191,037 376,127 42,462 Gregory T. Durant 55,243,731 334,922 30,973 Steven A. Kandarian 54,580,400 997,664 31,562 Derek G. Kirkland 55,245,410 330,570 33,646 Drew E. Lawton 55,247,068 330,675 31,883 Martin J. Lippert 55,196,393 381,587 31,746 Russell G. Noles 55,253,246 323,370 33,010 Laura L. Prieskorn 55,241,106 336,768 31,752 Esta E. Stecher 54,735,158 636,152 238,316 Broker Non-Vote : 6,963,701”

NIQ Global Intelligence plc shareholders approved Approval of capital reduction and creation of distributable reserves at the 2026-05-21 meeting.

“Approval of the capital reduction and the creation of distributable reserves (Special Resolution under Irish law): For Against Abstain Broker Non-Votes 265,704,195 180,946 131,352 0”

NIQ Global Intelligence plc shareholders approved Determination of price range for re-allotment of treasury shares at the 2026-05-21 meeting.

“Determination of the price range at which the Company can re-allot treasury shares (Special Resolution under Irish law): For Against Abstain Broker Non-Votes 265,720,147 219,500 76,846 0”

NIQ Global Intelligence plc shareholders approved Authorization for company or subsidiary to make market purchases of ordinary shares at the 2026-05-21 meeting.

“Authorization of the Company and/or any subsidiary of the Company to make market purchases of ordinary shares of the Company: For Against Abstain Broker Non-Votes 265,812,207 173,814 30,472 0”

NIQ Global Intelligence plc shareholders approved Advisory vote on frequency of future say-on-pay votes at the 2026-05-21 meeting.

“Approval, on an advisory basis, of the frequency of future advisory votes to approve the compensation of the Company’s named executive officers: 1 Year 2 Years 3 Years Abstain Broker Non-Votes 254,069,090 482 2,542,606 80,811 9,323,504”

NIQ Global Intelligence plc shareholders approved Advisory approval of executive compensation at the 2026-05-21 meeting.

“Approval, on an advisory basis, of the compensation of the Company’s named executive officers: For Against Abstain Broker Non-Votes 253,515,628 3,094,187 83,174 9,323,504”

NIQ Global Intelligence plc shareholders approved Ratification of Ernst & Young LLP as independent auditor for fiscal year 2026 and authorization to set auditor remuneration at the 2026-05-21 meeting.

“Ratification, in a non-binding advisory vote, of the selection of Ernst & Young LLP as the Company’s independent auditor for the fiscal year ending December 31, 2026 and authorization, in a binding vote, of the board of directors, acting through the audit committee, to set the independent auditor’s remuneration: For Against Abstain Broker Non-Votes 262,169,231 3,763,028 84,234 N/A”

NIQ Global Intelligence plc shareholders approved Election of four Class I director nominees at the 2026-05-21 meeting.

“Election, by separate resolutions, the four Class I director nominees named in this proxy statement to the board of directors, to serve until the conclusion of the Company’s 2029 annual general meeting: Nominees For Against Abstain Broker Non-Votes (a) Gabriela Weiss 247,651,204 8,958,730 83,055 9,323,504 (b) Racquel Harris Mason 247,027,754 9,581,581 83,654 9,323,504 (c) Charlotte Simonelli 244,049,036 12,560,898 83,055 9,323,504 (d) Todd Lachman 244,078,915 12,530,420 83,654 9,323,504”

Burlington Stores, Inc. shareholders approved Advisory vote on frequency of future say-on-pay votes at the 2026-05-19 meeting.

“4. Advisory Vote on Frequency of Future Say-On-Pay Votes Every 1 Year Every 2 Years Every 3 Years Abstained Broker Non-Votes 57,851,887 4,893 513,237 26,424 1,156,742”

Burlington Stores, Inc. shareholders approved Advisory vote regarding compensation of named executive officers at the 2026-05-19 meeting.

“3. Advisory Vote on Compensation of Named Executive Officers For Against Abstained Broker Non-Votes 51,330,197 6,993,967 72,277 1,156,742”

Burlington Stores, Inc. shareholders approved Ratification of appointment of Deloitte & Touche LLP as independent registered certified public accounting firm at the 2026-05-19 meeting.

“2. Ratification of Appointment of Independent Registered Certified Public Accounting Firm For Against Abstained Broker Non-Votes 57,429,806 2,105,955 17,422 N/A”

Burlington Stores, Inc. shareholders approved Election of seven directors at the 2026-05-19 meeting.

“The final voting results with respect to each proposal are set forth below. 1. Election of Directors Name For Against Abstained Broker Non-Votes Ted English 57,957,497 420,133 18,811 1,156,742”